119 related articles for article (PubMed ID: 23132105)
1. Ethical obligations under New Jersey's mandated pharmaceutical disclosures.
Schoppmann MJ
MD Advis; 2012; 5(4):26-8. PubMed ID: 23132105
[No Abstract] [Full Text] [Related]
2. Contact with pharmaceutical representatives: where does prudence lead?
Appelbaum PS
Am J Bioeth; 2010 Jan; 10(1):11-3. PubMed ID: 20077326
[No Abstract] [Full Text] [Related]
3. The details are in the field.
Schwab AP
Am J Bioeth; 2010 Jan; 10(1):19-21. PubMed ID: 20077330
[No Abstract] [Full Text] [Related]
4. Avoiding over-deterrence in managing physicians' relationships with industry.
Stell LK
Am J Bioeth; 2010 Jan; 10(1):27-9. PubMed ID: 20077334
[No Abstract] [Full Text] [Related]
5. Doctors and the drug industry: reader feedback.
Nardone DA
Am J Med; 2005 Oct; 118(10):1176-7; author reply 1177. PubMed ID: 16194658
[No Abstract] [Full Text] [Related]
6. Drug detailers, professionalism, and prudence.
Brody H
Am J Bioeth; 2010 Jan; 10(1):9-10. PubMed ID: 20077325
[No Abstract] [Full Text] [Related]
7. The devil in the detail(ing).
Morreim H
Am J Bioeth; 2010 Jan; 10(1):15-7. PubMed ID: 20077328
[No Abstract] [Full Text] [Related]
8. Huddle gets it right, most docs don't.
Rubin PH
Am J Bioeth; 2010 Jan; 10(1):17-9. PubMed ID: 20077329
[No Abstract] [Full Text] [Related]
9. Most Australians believe that drug company payments influence doctors' decisions.
Moynihan R
BMJ; 2012 Feb; 344():e1076. PubMed ID: 22331321
[No Abstract] [Full Text] [Related]
10. Response to open peer commentaries on "The pitfalls of deducing ethics from economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing".
Huddle TS
Am J Bioeth; 2010 Jan; 10(1):W1-3. PubMed ID: 20077322
[No Abstract] [Full Text] [Related]
11. Why academic medical centers should ban drug company gifts to individuals.
Strong C
Am J Bioeth; 2010 Jan; 10(1):13-5. PubMed ID: 20077327
[No Abstract] [Full Text] [Related]
12. Exploring the link between industry payments to doctors and prescribing habits.
Carlat D
BMJ; 2014 Nov; 349():g6651. PubMed ID: 25378357
[No Abstract] [Full Text] [Related]
13. The AAMC exhibits the behavior it condemns.
Stossel TP
Am J Bioeth; 2010 Jan; 10(1):26-7. PubMed ID: 20077333
[No Abstract] [Full Text] [Related]
14. The pitfalls of misreading: what does "industry funding of medical education" actually say?
Spielman B
Am J Bioeth; 2010 Jan; 10(1):24-5. PubMed ID: 20077332
[No Abstract] [Full Text] [Related]
15. The pitfalls of deducing ethics from behavioral economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing.
Huddle TS
Am J Bioeth; 2010 Jan; 10(1):1-8. PubMed ID: 20077321
[TBL] [Abstract][Full Text] [Related]
16. Public disclosure of conflicts of interest: moving the policy debate forward.
Campbell EG
Arch Intern Med; 2010 Apr; 170(8):667. PubMed ID: 20421548
[No Abstract] [Full Text] [Related]
17. Doctors and the drug industry: reader feedback.
Warrier R; Houghton B
Am J Med; 2005 Oct; 118(10):1175-6; author reply 1176. PubMed ID: 16194656
[No Abstract] [Full Text] [Related]
18. For sale: physicians' prescribing data.
Steinbrook R
N Engl J Med; 2006 Jun; 354(26):2745-7. PubMed ID: 16807410
[No Abstract] [Full Text] [Related]
19. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.
Moynihan R
BMJ; 2003 May; 326(7400):1189-92. PubMed ID: 12775621
[TBL] [Abstract][Full Text] [Related]
20. Icebreakers-unexpected outcomes.
Jamshed SQ; Mohamed Ibrahim MI; Hassali MA
J Coll Physicians Surg Pak; 2010 Feb; 20(2):142. PubMed ID: 20378048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
